Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Regression Models and Life-Tables

1992 • 27,454 citations

TNM Classification of Malignant Tumours

1987 • 16,209 citations

Evaluation of survival data and two new rank order statistics arising in its consideration.

1966 • 7,595 citations

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

1998 • 2,115 citations

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

1997 • 1,783 citations

Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

1999 • 1,315 citations

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.

1998 • 581 citations

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6

1994 • 435 citations

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.

1995 • 348 citations

Pathological assessment of response to induction chemotherapy in breast cancer.

1986 • 337 citations

Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm

1991 • 277 citations

Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer

1978 • 275 citations

Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate.

1993 • 271 citations

Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast

1994 • 255 citations

Multimodal treatment of locoregionally advanced breast cancer

1983 • 246 citations

Inflammatory Breast Cancer

1993 • 232 citations

Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.

1998 • 142 citations

Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer

2000 • 128 citations

Clinical and pathological response to primary chemotherapy in operable breast cancer

1997 • 125 citations

Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study

1985 • 94 citations

Neoadjuvant chemotherapy in 126 operable breast cancers☆

1992 • 92 citations

Treatment of locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery.

1986 • 76 citations

Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy

1997 • 49 citations

The Efficacy of Neoadjuvant Chemotherapy Compared to Postoperative Therapy in the Treatment of Locally Advanced Breast Cancer

1998 • 45 citations

A phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma

1998 • 40 citations

Primary Tumor Response to Induction Chemotherapy as a Predictor of Histological Status of Axillary Nodes in Operable Breast Cancer Patients

1999 • 33 citations

Phase II Study of Sequential Administration of Docetaxel Followed by Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer

2001 • 19 citations